Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-049410·ALX ONCOLOGY HOLDINGS INC
Schedule 13G ownership disclosure
ALX Oncology Holdings, Inc.
Common Stock, par value $0.001 per share · CUSIP: 00166B105
Event date: 2025-03-31
- Filing-level shares
- 4,500,000.00
- Percent of class
- 8.4%
- HBM Healthcare Investments (Cayman) Ltd.
Shares: 4,500,000.00 · Class: 8.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-049410
- Form type
- SCHEDULE 13G/A
- Filer
- ALX ONCOLOGY HOLDINGS INC
- CIK
- CIK 1810182
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership